GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Equity-to-Asset

Kyowa Kirin Co (TSE:4151) Equity-to-Asset : 0.81 (As of Sep. 2023)


View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kyowa Kirin Co's Total Stockholders Equity for the quarter that ended in Sep. 2023 was 円812,143 Mil. Kyowa Kirin Co's Total Assets for the quarter that ended in Sep. 2023 was 円1,004,051 Mil. Therefore, Kyowa Kirin Co's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.81.

The historical rank and industry rank for Kyowa Kirin Co's Equity-to-Asset or its related term are showing as below:

TSE:4151' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.8   Med: 0.86   Max: 0.88
Current: 0.81

During the past 13 years, the highest Equity to Asset Ratio of Kyowa Kirin Co was 0.88. The lowest was 0.80. And the median was 0.86.

TSE:4151's Equity-to-Asset is ranked better than
82.67% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs TSE:4151: 0.81

Kyowa Kirin Co Equity-to-Asset Historical Data

The historical data trend for Kyowa Kirin Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Equity-to-Asset Chart

Kyowa Kirin Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 0.87 0.87 0.80 0.81

Kyowa Kirin Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.81 0.81 0.82 0.81 0.81

Competitive Comparison of Kyowa Kirin Co's Equity-to-Asset

For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kyowa Kirin Co's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Kyowa Kirin Co's Equity-to-Asset falls into.



Kyowa Kirin Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Kyowa Kirin Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=762826/939881
=0.81

Kyowa Kirin Co's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )=Total Stockholders Equity/Total Assets
=812143/1004051
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kyowa Kirin Co  (TSE:4151) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Kyowa Kirin Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Kyowa Kirin Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Kyowa Kirin Co (TSE:4151) Business Description

Traded in Other Exchanges
Address
1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines